BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 12/08/2022

Galephar Pharmaceutical Research, Inc. Seeks Registration as Controlled Substance Importer

Galephar Pharmaceutical Research, Inc. has submitted an application to the relevant authorities to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →